There are 410 resources available
HER2 alterations: Past, present and future
Presenter: Antonio Passaro
Session: Genomic alterations beyond EGFR and ALK
Resources:
Slides
Webcast
Biological insights for selection of peri-operative strategies
Presenter: Giannis Mountzios
Session: Peri-operative strategies in early stage NSCLC with IO and targeted therapies
Resources:
Slides
Webcast
Q&A
Presenter: Nicolas Girard
Session: Stage III thymoma
Resources:
Webcast
Q&A
Presenter: Antonio Passaro
Session: Genomic alterations beyond EGFR and ALK
Resources:
Webcast
Introduction and first vote
Presenter: Corinne Faivre-Finn
Session: Stereotactic RT vs surgery in early stage NCSLC
Resources:
Slides
Webcast
Yes
Presenter: Umberto Ricardi
Session: Stereotactic RT vs surgery in early stage NCSLC
Resources:
Slides
Webcast
Managing acquired resistance to immunotherapy in NSCLC: Resistance mechanisms and treatment strategies
Presenter: Maurice Perol
Session: Resistance after IO and targeted therapies: Patterns of emergence and management
Resources:
Slides
Webcast
No
Presenter: Paul van Schil
Session: Stereotactic RT vs surgery in early stage NCSLC
Resources:
Slides
Webcast
Current indications of precision therapeutics in advanced oncogene-addicted NSCLC beyond EGFR and ALK: Efficacy, safety, value
Presenter: Benjamin Besse
Session: ESMO Colloquium supported by Eli Lilly & Company - Precision oncology beyond EGFR/ALK for NSCLC in 2023: Test, target, manage
Resources:
Webcast
Managing acquired resistance to targeted therapy in NSCLC: Resistance mechanisms and treatment strategies
Presenter: Zofia Piotrowska
Session: Resistance after IO and targeted therapies: Patterns of emergence and management
Resources:
Slides
Webcast